The HDAC Inhibitor Quisinostat (JNJ-26481585) Supresses Hepatocellular Carcinoma alone and Synergistically in Combination with Sorafenib by G0/G1 phase arrest and Apoptosis induction
about
The HDAC Inhibitor Quisinostat (JNJ-26481585) Supresses Hepatocellular Carcinoma alone and Synergistically in Combination with Sorafenib by G0/G1 phase arrest and Apoptosis induction
description
im Jahr 2018 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2018
@uk
name
The HDAC Inhibitor Quisinostat ...... arrest and Apoptosis induction
@en
The HDAC Inhibitor Quisinostat
@nl
type
label
The HDAC Inhibitor Quisinostat ...... arrest and Apoptosis induction
@en
The HDAC Inhibitor Quisinostat
@nl
prefLabel
The HDAC Inhibitor Quisinostat ...... arrest and Apoptosis induction
@en
The HDAC Inhibitor Quisinostat
@nl
P2093
P2860
P356
P1476
The HDAC Inhibitor Quisinostat ...... arrest and Apoptosis induction
@en
P2093
Haiyang Xie
Jingbang Wu
Longfei Dai
Shusen Zheng
Xiaode Feng
Xiaoqian Zhang
P2860
P304
P356
10.7150/IJBS.27661
P407
P577
2018-01-01T00:00:00Z